NPI: 1427026756 · PANAMA CITY, FL 32405 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/11/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 03/11/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,793 | $874K |
| 2019 | 2,885 | $341K |
| 2020 | 5,427 | $740K |
| 2021 | 2,392 | $275K |
| 2022 | 2,990 | $613K |
| 2023 | 1,814 | $262K |
| 2024 | 603 | $39K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 10,724 | 835 | $1.22M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,057 | 427 | $999K |
| J1270 | Injection, doxercalciferol, 1 mcg | 4,694 | 330 | $359K |
| J1756 | Injection, iron sucrose, 1 mg | 1,488 | 337 | $196K |
| A4657 | Syringe, with or without needle, each | 1,026 | 532 | $191K |
| 83550 | 341 | 273 | $33K | |
| 83540 | 340 | 272 | $33K | |
| 82728 | 333 | 272 | $28K | |
| 83970 | 250 | 162 | $25K | |
| 85041 | 173 | 136 | $20K | |
| 85048 | 172 | 135 | $20K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 97 | 71 | $15K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 178 | 75 | $4K |
| 82108 | 31 | 28 | $0.00 |